U.S. Keeps Colombia on Drug-Control Failure List but Leaves Door Open for Review
Bogotá, September 17, 2026: The United States has retained Colombia on its list of countries that Washington says failed demonstrably during the previous 12 months to meet international counternarcotics commitments. The decision was included in the U.S. presidential determination for fiscal year 2027.
Colombia is one of four countries specifically identified in the determination, alongside Afghanistan, Bolivia and Burma. The wider U.S. list contains 23 countries considered major sources or transit locations for illicit drugs.
Despite maintaining the designation, the Trump administration has decided that continued U.S. assistance to Colombia remains in the American national interest. This means the classification does not automatically result in the suspension of U.S. assistance. Colombian media reported that the country received an interest-based waiver alongside the designation.
The announcement also included a possible path toward changing Colombia’s status in the future. U.S. President Donald Trump said Washington could reconsider the designation if Colombia makes measurable progress in coca eradication and dismantling drug-trafficking networks over the coming year.
The decision comes shortly after Colombia’s newly elected President Abelardo De La Espriella took office. The U.S. administration has indicated that it expects the new government to intensify counternarcotics operations.
The timing is significant because the U.S. assessment covers the previous 12-month period rather than simply the performance of Colombia’s new administration. Colombian reporting has therefore highlighted the distinction between the period evaluated by Washington and the policies of the newly installed government.
The United States has also recently increased security cooperation with several Latin American governments. Washington announced that $52 million in military assistance would be redirected from several European and Middle Eastern countries toward Panama, Peru, Ecuador and Colombia, with counternarcotics and regional security among the stated priorities.
For Colombia, the latest decision keeps the country’s counternarcotics policy under close international scrutiny while preserving U.S. security assistance. The next annual assessment will depend on the results Colombia records in reducing coca cultivation, disrupting trafficking organizations and implementing its broader drug-control strategy.
The development is therefore likely to remain an important issue in Colombia-U.S. relations, particularly as both governments seek closer cooperation on security and organized crime.
